Publication:
Sex-related differences in self-reported treatment burden in patients with atrial fibrillation

dc.contributor.authorMihajlovic, Miroslav (57207498211)
dc.contributor.authorSimic, Jelena (57201274633)
dc.contributor.authorMarinkovic, Milan (56160715300)
dc.contributor.authorKovacevic, Vladan (57190845395)
dc.contributor.authorKocijancic, Aleksandar (36016706900)
dc.contributor.authorMujovic, Nebojsa (16234090000)
dc.contributor.authorPotpara, Tatjana S. (57216792589)
dc.date.accessioned2025-06-12T12:31:32Z
dc.date.available2025-06-12T12:31:32Z
dc.date.issued2022
dc.description.abstractBackground: Treatment burden (TB) is defined as the patient’s workload of healthcare and its impact on patient functioning and wellbeing. High TB can lead to non-adherence, a higher risk of adverse outcomes and lower quality of life (QoL). We have previously reported a higher TB in patients with atrial fibrillation (AF) vs. those with other chronic conditions. In this analysis, we explored sex-related differences in self-reported TB in AF patients. Materials and methods: A single-center, prospective study included consecutive patients with AF under drug treatment for at least 6 months before enrollment from April to June 2019. Patients were asked to voluntarily and anonymously answer the Treatment Burden Questionnaire (TBQ). All patients signed the written consent for participation. Results: Of 331 patients (mean age 65.4 ± 10.3 years, mean total AF history 6.41 ± 6.62 years), 127 (38.4%) were females. The mean TB was significantly higher in females compared to males (53.7 vs. 42.6 out of 170 points, p < 0.001), and females more frequently reported TB ≥ 59 points than males (37.8% vs. 20.6%, p = 0.001). In females, on multivariable analysis of the highest TB quartile (TB ≥ 59), non-vitamin K Antagonist Oral Anticoagulant (NOAC) use [Odds Ratio (OR) 0.319; 95% Confidence Interval (CI) 0.12–0.83, P = 0.019], while in males, catheter ablation and/or ECV of AF (OR 0.383; 95% CI 0.18–0.81, P = 0.012) were negatively associated with the highest TB quartile. Conclusion: Our study was the first to explore the sex-specific determinants of TB in AF patients. Females had significantly higher TB compared with males. Approximately 2 in 5 females and 1 in 5 males reported TB ≥ 59 points, previously shown to be an unacceptable burden of treatment for patients. Using a NOAC rather than vitamin K antagonist (VKA) in females and a rhythm control strategy in males could decrease TB to acceptable values. Copyright © 2022 Mihajlovic, Simic, Marinkovic, Kovacevic, Kocijancic, Mujovic and Potpara.
dc.identifier.urihttps://doi.org/10.3389/fcvm.2022.1029730
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85142288666&doi=10.3389%2ffcvm.2022.1029730&partnerID=40&md5=205eb1a6a82b0dbeef69a2d8d3572086
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/3158
dc.subjectatrial fibrillation
dc.subjectfemale sex
dc.subjectquality of life
dc.subjectsex-related differences
dc.subjecttreatment burden
dc.titleSex-related differences in self-reported treatment burden in patients with atrial fibrillation
dspace.entity.typePublication

Files